Fig. 4From: Histone acetylation: a key determinant of acquired cisplatin resistance in cancerEnrichment of H3K27Ac in response to cisplatin treatment. Bar graph representing percent input enrichment of H3K27Ac on the promoter of depicted genes. The comparison carried out between parental & resistance w or w/o treated with cisplatin. Error bar represents mean ± S.D from 3 replicates. *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001Back to article page